Caristo Diagnostics has been formed to bring revolutionary cardiovasular diagnostic tools to patients worldwide. Our proprieraty technology transforms the accuracy of routine cardiac CT scans by extracting new information that is otherwise invisible, greatly enhancing the power to predict cardiovascular risk and refine treatment decisions.
Our Website: https://www.caristo.com
Follow us on Twitter: https://twitter.com/CaristoHeart
Our Website: https://www.caristo.com
Follow us on Twitter: https://twitter.com/CaristoHeart
Location: United Kingdom, England, Oxford
Employees: 11-50
Total raised: $16.3M
Founded date: 2017
Investors 5
| Date | Name | Website |
| - | Oxford Uni... | innovation... |
| - | Oxford Inv... | oxfordinve... |
| 01.06.2021 | Creative D... | creativede... |
| - | Oxford Sci... | oxfordscie... |
| 05.05.2021 | BGF Ventur... | bgf.co.uk |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 17.04.2023 | Series A | $16.3M | Longwall V... |
Mentions in press and media 12
| Date | Title | Description |
| 30.09.2024 | HEARTX CARDIOVASCULAR ACCELERATOR ANNOUNCES FOUR STARTUP COMPANIES SELECTED FOR THE 2024 PROGRAM | HeartX, powered by HealthTech Arkansas and MedAxiom — along with numerous leading cardiology practices in Arkansas and around the country — has selected four startup healthcare companies to participate in its 2024 accelerator program. Heart... |
| 06.09.2024 | The Hidden Crisis: Micronutrient Deficiency Affects Half the World’s Population | A silent epidemic is sweeping across the globe. More than half of the world’s population is grappling with a deficiency in essential micronutrients. This alarming revelation comes from a groundbreaking study conducted by researchers from Ha... |
| 03.09.2024 | Caristo Diagnostics Recognized as Quarterfinalist in the Digital Health Awards, Rising Star Category | OXFORD, England, Sept. 3, 2024 /PRNewswire/ -- Caristo Diagnostics, a global leader in cardiovascular disease diagnostics and risk prediction, has been selected as a quarterfinalist for the prestigious Digital Health Hub Foundation: Digital... |
| 18.04.2023 | Oxford-based Caristo Diagnostics bags €14.7M for AI-powered cardiac disease detection; appoints new CEO | Oxford-based Caristo Diagnostics, a company that specialises in cardiac and vascular disease diagnostics and risk prediction, announced on Monday, April 18, that it has secured £13M (approximately €14.7M) in its Series A financing round. Th... |
| 17.04.2023 | Caristo Diagnostics Completes US$16.3M Series A Financing | Caristo Diagnostics, an Oxford, UK-based biotechnology company which specializes in cardiac and vascular disease diagnostics and risk prediction, raised US$16.3M in Series A funding. The round was led by Oxford Science Enterprises and joine... |
| 14.10.2020 | Introducing: The 32 companies joining Applied AI 2.0 | Today we are excited to introduce the 32 companies who have been selected to join Applied AI 2.0, our growth programme for tech companies with artificial intelligence at their core. Now in its second year, our Applied AI 2.0 forms part of t... |
| 08.11.2019 | Cambridge companies recognised at industry leading OBN Awards 2019 event | Cambridge companies recognised at industry leading OBN Awards 2019 event 08-11-2019 Cambridge Network members Bicycle Therapeutics and Endomag have been honoured at the 2019 OBN Awards, which celebrate the best of UK life sciences. OBN (UK)... |
| - | Caristo Diagnostics | “Caristo Diagnostics” |
| - | MIP Diagnostics secures £5.1m in funding | Nanotechnology business, MIP Diagnostics, has completed a £5.1m funding round to accelerate its global expansion. The co-investment has come from Mercia Asset Management, a founding investor and the largest shareholder in the company, and w... |
| - | The Lancet Publishes Results from World's Largest Coronary CT Registry Showing New AI Technology Can Predict Cardiac Events Due to Coronary Inflammation At Least 10 Years in Advance | OXFORD, England, May 30, 2024 /PRNewswire/ -- Caristo Diagnostics Limited, a global leader in cardiovascular disease diagnostics and risk prediction, announced the results of a landmark clinical study published in The Lancet that support th... |
Show more